Northern Trust
PLRX icon

Northern Trust’s Pliant Therapeutics PLRX Stock Holding History

Northern Trust’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143K Sell
125,060
-29,116
-19% -$35.4K ﹤0.01% 4025
2026
Q1 		$194K Buy
154,176
+30,903
+25% +$39K ﹤0.01% 3958
2025
Q4 		$150K Sell
123,273
-13,227
-10% -$19.9K ﹤0.01% 4060
2025
Q3 		$202K Sell
136,500
-28,940
-17% -$44.2K ﹤0.01% 3981
2025
Q2 		$192K Sell
165,440
-343,641
-68% -$486K ﹤0.01% 3950
2025
Q1 		$687K Sell
509,081
-46,519
-8% -$282K ﹤0.01% 3437
2024
Q4 		$7.32M Buy
555,600
+53,584
+11% +$732K ﹤0.01% 2300
2024
Q3 		$5.63M Buy
502,016
+24,851
+5% +$311K ﹤0.01% 2409
2024
Q2 		$5.13M Sell
477,165
-18,124
-4% -$234K ﹤0.01% 2390
2024
Q1 		$7.38M Sell
495,289
-10,037
-2% -$166K ﹤0.01% 2240
2023
Q4 		$9.15M Buy
505,326
+370
+0.1% +$5.63K ﹤0.01% 2129
2023
Q3 		$8.76M Buy
504,956
+14,165
+3% +$246K ﹤0.01% 2096
2023
Q2 		$8.89M Buy
490,791
+387,124
+373% +$9.16M ﹤0.01% 2148
2023
Q1 		$2.76M Buy
103,667
+22,295
+27% +$635K ﹤0.01% 2804
2022
Q4 		$1.57M Buy
81,372
+25,071
+45% +$524K ﹤0.01% 3109
2022
Q3 		$1.18M Buy
56,301
+18,540
+49% +$355K ﹤0.01% 3260
2022
Q2 		$302K Sell
37,761
-175,908
-82% -$1.13M ﹤0.01% 3721
2022
Q1 		$1.5M Sell
213,669
-14,782
-6% -$151K ﹤0.01% 3243
2021
Q4 		$3.08M Buy
228,451
+3,631
+2% +$57.7K ﹤0.01% 2993
2021
Q3 		$3.79M Buy
224,820
+8,698
+4% +$185K ﹤0.01% 2912
2021
Q2 		$6.29M Sell
216,122
-5,970
-3% -$186K ﹤0.01% 2709
2021
Q1 		$8.73M Buy
222,092
+100,556
+83% +$3.27M ﹤0.01% 2382
2020
Q4 		$2.76M Buy
121,536
+322
+0.3% +$8.07K ﹤0.01% 3018
2020
Q3 		$2.75M Buy
+121,214
New +$3.03M ﹤0.01% 2891

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Northern Trust's PLRX Position: Q2 2026 in Review

Northern Trust reduced its Pliant Therapeutics (PLRX) stake by 19% in Q2 2026, selling an estimated $35.4K and leaving 125,060 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #4025.

Northern Trust first reported a position in PLRX in Q3 2020 and has held it in 24 quarters since. The position peaked at $9.15M in Q4 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Northern Trust held 125,060 shares of Pliant Therapeutics worth $143K as of Q2 2026.
  • Northern Trust sold 29,116 Pliant Therapeutics shares in Q2 2026, an estimated $35.4K.
  • Pliant Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4025 holding.
  • Northern Trust first reported a position in Pliant Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • Northern Trust's Pliant Therapeutics position peaked at $9.15M in Q4 2023.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.